Fredun Pharmaceuticals Ltd

Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday February 09 2026 has inter-alia considered adopted and approved following business item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the Quarter and Nine Months Ended 31st December 2025 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co Statutory Auditors of the Company; copies of which are attached hereunder; In furtherance to the intimation filed by the Company dated January 30 2026; the trading window for trading in securities of the Company by designated persons and their immediate relatives closed on January 01 2026 till the end of 48 hours after the declaration of outcome of Board Meeting.